The Not-So-Subtle Reason Behind Perrigo Company PLC's 13% Move Higher
Shares of Perrigo (NYSE: PRGO), a provider of consumer goods and over-the-counter pharmaceutical products, rocketed higher by as much as 13% during Thursday's trading session after the company reported its third-quarter earnings results. As you can likely surmise by the move higher, it was smiles all around for Wall Street and shareholders (for a change).
For the quarter, Perrigo reported adjusted net sales of $1.22 billion, down 2% from the year-ago quarter, or 3% on a constant-currency basis. If divestments are excluded, adjusted net sales would have actually risen by 3% sans currency movements. Highlights for the company included 5% net sales growth from its consumer healthcare international segment, and 4% net sales growth in prescription pharmaceuticals, excluding a $10 million year-over-year impact to Entocort.
Image source: Getty Images.
Source: Fool.com
Perrigo Co. plc Stock
Our community is currently high on Perrigo Co. plc with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 35 € shows a positive potential of 34.2% compared to the current price of 26.08 € for Perrigo Co. plc.
